MarketPulse

biotech leadership

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Anaveon Ag

Biotech Veteran Ramanayake Takes Helm at Anaveon as Immune Reprogramming Firm Pursues Clinical Trials

Anaveon appoints veteran biotech executive Thaminda Ramanayake as CEO to guide lead candidate ANV200 through clinical development for autoimmune and inflammatory diseases.
PFENVSBNTXclinical developmentautoimmune diseases
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Vesicor Therapeutics Appoints Veteran Biotech Executive Tolentino as CEO Ahead of SPAC Merger

Vesicor Therapeutics names Michael Tolentino as CEO effective March 2026, succeeding founder Luo Feng. Leadership transition precedes de-SPAC merger completion and 2027 FDA submission.
BKHABKHARBKHAUSPAC mergerCEO appointment